chartexchange

BioArctic collaborator Novartis terminates agreement

PR Newswire | Nov 2, 2026 4:14 PM EST

STOCKHOLM, Nov. 2, 2026 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that Novartis Pharma AG has notified BioArctic that it has decided to terminate the Option, Collaboration and License Agreement entered into in August 2025 to explore a potential new...

Read original article